Pharmascience Inc News Today

Three pharmaceutical companies are recalling all lots of their prescription generic medication over concerns about the integrity of test data

Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The

In a 2022 decision involving Janssen and Pharmascience, the Federal Court found that the claims of Canadian Patent No. 2,655,335 (335 patent, relating to paliperidone palmitate...

In our annual review of developments in Canadian patent law, we considered over 60 patent decisions reported last year. This article highlights statutory changes and a selection of...

There are currently no events scheduled on LIVE1. Check back soon to watch live events from across Canada and the world!

Health Canada has issued a recall for Cromolyn Eye Drops, an over-the-counter medication used to relieve symptoms of allergy-induced pink eye in adults and children aged five and older. The recall comes after the Pendopharm division of Pharmascience Inc., the manufacturer, found that the product's preservative was not as effective as expected, leading to an…

Health Canada is recalling a brand of eye drops, saying use of the product may cause microbial growth, leading to the risk of an eye infection.

After reports were made regarding the presence of nitrosamines in certain pharmaceutical products in 2018 and 2019, and subsequent precautionary regulatory action was taken, an...

After reports were made regarding the presence of nitrosamines in certain pharmaceutical products in 2018 and 2019, and subsequent precautionary regulatory action was taken, an avalanche of litigation commenced in Canada and the United States regarding alleged failures by drug manufacturers, wholesalers, distributors and retailers in respect of a host of pharmaceutical products, including Losartan, Valsartan, Ranitidine and others.

Operator: Greetings and welcome to the IntelGenx First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen-only mode.